ProteoMediX AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ProteoMediX AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10380
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProteoMediX AG (ProteoMediX) is a medical diagnostic company that identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment. The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection of prostate cancer. Its biomarkers are discovered using a genetics-guided discovery approach and are used in detecting PI3K/PTEN cancer pathway. ProteoMediX offers proteomics technologies, which are used to analyze glycosylated proteins in prostate tissue and serum from wild-type mice and mice with prostate-specific deletion of the tumor suppressor PTEN. The company serves patients with prostate and other types of cancer. ProteoMediX is headquartered in Schlieren, Switzerland.

ProteoMediX AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProteoMediX AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProteoMediX AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ProteoMediX AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProteoMediX AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ProteoMediX AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ProteoMediX AG, Medical Equipment, Deal Details 10
Venture Financing 10
ProteoMediX Raises USD5.3 Million in Venture Financing 10
ProteoMediX Raises USD5 million in Financing Round 11
ProteoMediX Raises USD1.1 Million in Extended Series B Venture Financing 12
ProteoMediX Raises US$3.6 Million In Series B Financing 13
ProteoMediX Raises US$2.7 Million In Series A Financing 14
ProteoMediX AG – Key Competitors 15
ProteoMediX AG – Key Employees 16
ProteoMediX AG – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jun 21, 2017: Dr. Helge Lubenow elected as a new member to the Board of Directors 18
Legal and Regulatory 19
Jan 13, 2017: ProteoMediX receives ISO 13485:2012 Certification 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
ProteoMediX AG, Medical Equipment, Key Facts 2
ProteoMediX AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ProteoMediX AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProteoMediX AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ProteoMediX AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProteoMediX AG, Deals By Market, 2012 to YTD 2018 8
ProteoMediX AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ProteoMediX Raises USD5.3 Million in Venture Financing 10
ProteoMediX Raises USD5 million in Financing Round 11
ProteoMediX Raises USD1.1 Million in Extended Series B Venture Financing 12
ProteoMediX Raises US$3.6 Million In Series B Financing 13
ProteoMediX Raises US$2.7 Million In Series A Financing 14
ProteoMediX AG, Key Competitors 15
ProteoMediX AG, Key Employees 16

List of Figures
ProteoMediX AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ProteoMediX AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ProteoMediX AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ProteoMediX AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ProteoMediX AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProteoMediX AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ProteoMediX AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProteoMediX AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ProteoMediX AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banesco Banco Universal C.A.:企業の戦略・SWOT・財務情報
    Banesco Banco Universal C.A. - Strategy, SWOT and Corporate Finance Report Summary Banesco Banco Universal C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Landry’s Inc:企業の戦略・SWOT・財務情報
    Landry's Inc - Strategy, SWOT and Corporate Finance Report Summary Landry's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Monogram Biosciences Inc:企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Gulfport Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Gulfport Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Gulfport Energy Corp (Gulfport) is an oil and gas company that explores, develops and produces oil and natural gas. The company operates its oil and gas exploration and development assets in Uti …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China General Technology (Group) Holding Ltd:企業の戦略・SWOT・財務分析
    China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Argon Medical Devices Inc:医療機器:M&Aディール及び事業提携情報
    Summary Argon Medical Devices Inc (Argon) is a medical device company that manufactures and supplies products for the dialysis and others. The company provides arterial catheters, temporary pacing electrode trays, pulmonary artery and thermodilution catheters, and single lumen central venous cathete …
  • Owens Corning (OC):企業の財務・戦略的SWOT分析
    Owens Corning (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MolMed SpA (MLM):製薬・医療:M&Aディール及び事業提携情報
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Lenovo Group Limited:企業の戦略・SWOT・財務分析
    Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report Summary Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Baron Oil Plc (BOIL):企業の財務・戦略的SWOT分析
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It also holds working interests of Nancy Burdine Maxine oil field, oil …
  • Ellomay Capital Ltd (ELLO):企業の財務・戦略的SWOT分析
    Summary Ellomay Capital Ltd (Ellomay), formerly NUR Macroprinters Ltd, is an energy and infrastructure consulting company that provides renewable energy, oil and gas exploration, and clean energy solutions. The company offers renewable energy services such as installation of photovoltaic plants, man …
  • Acxiom Corp (ACXM):企業の財務・戦略的SWOT分析
    Acxiom Corp (ACXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Hubbell Inc (HUBB):企業の財務・戦略的SWOT分析
    Hubbell Inc (HUBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Thaivivat Insurance Public Company Limited
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Tokyo Seimitsu Co., Ltd. (7729):企業の財務・戦略的SWOT分析
    Tokyo Seimitsu Co., Ltd. (7729) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Asia Commercial Joint Stock Bank:企業の戦略・SWOT・財務情報
    Asia Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Asia Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Swift Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆